๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shenyang
Clinical trial register · China

Clinical Trials in Shenyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shenyang 46 Harbin 2 Changchun 2 Dalian 2 Panjin 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shenyang46 Harbin2 Changchun2 Dalian2 Panjin2
All 5 locations
Target enrolment
to

Trials with a site in Shenyang

46 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Culmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast Cancer
NCT07795424Breast Cancer, HR Positive, HER2 Positive Breast Cancer
Shengjing Hospital
Phase 2
33
Shenyang
2026-09-01
Not yet open
Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT
NCT07768085Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Hepatic Metastasis, Hepatic Hemangioma
Shengjing Hospital
Not applicable
40,000
Shenyang
2026-08-17
Not yet open
Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI
NCT07704268Spinal Cord Injuries
Shengjing Hospital
Not applicable
44
Shenyang
2026-07-10
Not yet open
Effect of Cerebellar Fastigial Nucleus Stimulation Combined With Sling Exercise on Motor Function in Hemiplegic Stroke Patients
NCT07670936Stroke
Shengjing Hospital
Not applicable
54
Shenyang
2026-07-01
By invitation
Interventional AI-Human Collaboration for Steatotic Liver Disease Screening
NCT07613827Steatotic Liver Disease, Liver Fibrosis Progression in Chronic Liver Disease, Liver Steatosis, Liver Fibrosis
Shengjing Hospital
Not applicable
7,969
Shenyang
2026-02-24
Recruiting
Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury
NCT07106060SCI - Spinal Cord Injury, Motor Imagery, Brain-Computer Interfaces
Shengjing Hospital
Not applicable
36
Shenyang
2025-01-01
Recruiting
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
NCT06779058Chronic Hepatitis B, Liver Fibrosis
Shengjing Hospital
Observational
600
Shenyang
2025-01-01
Recruiting
Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
NCT07050069Spinal Cord Injuries
Shengjing Hospital
Not applicable
60
Shenyang
2024-12-25
Recruiting
fNIRS-Driven Visual Feedback Training to Restore Walking After Stroke
NCT07014891Stroke
Shengjing Hospital
Not applicable
44
Shenyang
2024-12-15
Recruiting
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679Breast Cancer
Shengjing Hospital
Observational
1,000
Shenyang
2024-11-15
Recruiting
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
NCT06690645Breast Cancer
Shengjing Hospital
Observational
840
Shenyang
2024-11-15
Recruiting
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
NCT06340230HR Positive/HER2 Low Breast Cancer
Shengjing Hospital
Phase 2
93
Shenyang
2024-08-23
Recruiting
Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
NCT06452862Diabetic Kidney Disease
Shengjing Hospital
Observational
150
Shenyang
2024-06-06
Not yet open
Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer
NCT06202313Triple Negative Breast Cancer
Shengjing Hospital
Phase 2
128
Shenyang
2024-02-10
Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
NCT06208397Metastatic Colorectal Cancer
Shengjing Hospital
Observational
50
Shenyang
2023-12-24
Recruiting
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
NCT06165900Stereotactic Radiotherapy, Immunotherapy, Breast Cancer
Shengjing Hospital
Phase 2
136
Shenyang
2023-09-26
Active, closed
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment
NCT05132790Breast Cancer
Shengjing Hospital
Not applicable
24
Shenyang
2023-09-25
Recruiting
A Clinical Study of Hyperthyroidism in Children
NCT06570967Hyperthyroidism
Shengjing Hospital
Observational
1,000
Shenyang
2023-07-18
Recruiting
A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients
NCT05635487HER2-positive Breast Cancer
Shengjing Hospital
Phase 2
65
Shenyang
2023-03-16
Recruiting
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NCT05957679Spinal Cord Tumors
Shengjing Hospital
Not applicable
20
Shenyang
2023-01-01
Recruiting
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
NCT06955208Meningioma
Shengjing Hospital
Not applicable
300
Shenyang
2022-10-19
Recruiting
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
NCT06202235Chronic Kidney Disease (CKD)
Shengjing Hospital
Observational
200
Shenyang
2022-10-10
Recruiting
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015Cirrhosis, Liver, Portal Hypertension, Advanced Chronic Liver Disease
Shengjing Hospital
Observational
150
Shenyang
2022-08-16
Recruiting
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
NCT06205992Cirrhosis, Liver Portal Hypertension
Shengjing Hospital
Observational
100
Shenyang
2022-08-16
Recruiting
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
NCT05263570Breast Cancer
Shengjing Hospital
Observational
200
Shenyang
2022-08-01
Recruiting
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
NCT05228951Breast Cancer
Shengjing Hospital
Phase 2
12
Shenyang
2022-02-10
Recruiting
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
NCT05241119Breast Cancer
Shengjing Hospital
Not applicable
100
Shenyang
2021-11-01
Recruiting
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
NCT04983121Breast Neoplasms
Shengjing Hospital
Phase 2
30
Shenyang
2021-08-01
Not yet open
Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy
NCT04973319Breast Cancer
Shengjing Hospital
Phase 3
450
Shenyang
2021-08-01
Recruiting
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
NCT04136782Breast Cancer
Shengjing Hospital
Phase 4
110
Harbin, Changchun, Dalian, Panjin, Shenyang
2021-07-19
Recruiting
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
NCT04137653Breast Cancer
Shengjing Hospital
Phase 3
1,498
Shenyang
2021-07-19
Recruiting
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
NCT04476485Breast Cancer
Shengjing Hospital
Observational
1,000
Harbin, Changchun, Dalian, Panjin, Shenyang
2021-07-19
Recruiting
Psychological Screening and Nursing of Twin Pregnancy
NCT05182541Twin; Complicating Pregnancy, Psychology
Shengjing Hospital
Not applicable
100
Shenyang
2021-03-01
Recruiting
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
NCT05098769Pulmonary Embolism and Thrombosis, Deterioration, Clinical
Shengjing Hospital
Observational
300
Shenyang
2021-01-18
Active, closed
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
NCT04486911Breast Cancer
Shengjing Hospital
Phase 2
89
Shenyang
2020-07-27
Recruiting
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
NCT04065321Breast Neoplasms
Shengjing Hospital
Observational
500
Shenyang
2019-10-01
Not yet open
Combination Therapy of Anthracyclines for Children With Nephroblastoma
NCT038923300.5-14 Year Old Children With Nephroblastoma
Shengjing Hospital
Phase 4
120
Shenyang
2019-06-01
Recruiting
The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression
NCT07779005Lung Caner
Shengjing Hospital
Observational
1,500
Shenyang
2019-02-01
Recruiting
Birth Cohort Study of China Medical University
NCT03561766Twin; Complicating Pregnancy, Advanced Maternal Age Pregnancy, Scarred Uterus, Overweight and Obesity
Shengjing Hospital
Observational
1,000
Shenyang
2018-06-15
Active, closed
MR Elastography in Intracranial Lesions: Feasibility & Accuracy
NCT06916715Brain Neoplasms
Shengjing Hospital
Observational
626
Shenyang
2017-05-09
Recruiting
Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
NCT05990244Glioma
Shengjing Hospital
Not applicable
100
Shenyang
2017-01-01
Recruiting
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
NCT05482269Pulmonary Embolism and Thrombosis, Deterioration, Clinical, Artificial Intelligence
Shengjing Hospital
Observational
2,000
Shenyang
2011-01-01
Active, closed
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
NCT05481242Pulmonary Embolism and Thrombosis, Deterioration, Clinical
Shengjing Hospital
Observational
2,000
Shenyang
2011-01-01
Rows per page Showing 1–46 of 46
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shenyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 46 of those studies with a site in Shenyang that also match the filters currently applied.

How many clinical trials are recruiting in Shenyang?

34 of the 46 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 7 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenyang), 46 studies
PhaseStudiesRecruitingShare
Observational191741.3%
Not applicable14930.4%
Phase 29619.6%
Phase 3214.3%
Phase 4214.3%

Most active sponsors

Lead sponsors with the most studies (Shenyang)
Lead sponsorStudiesRecruiting
Shengjing Hospital4634
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.